“The viagra is going to cost us $400 billion,” Trump said during a press conference at the White House on Friday.
“So, let me say, do not worry, we’re going to have it right here, right now, and we’re not going to be paying that much.”
Trump also said he would give up on a plan to allow drug makers to build their own drug, and instead would let the Food and Drug Administration approve the drug for use by Americans.
The president’s statement was a clear signal to drug makers that he would continue to block their efforts to develop new drugs for the elderly.
But it also came with a warning that the White Houses plans to keep on the offensive against drug makers.
“We are not going back,” Trump warned.
“We are going to do everything in our power to stop the manufacturing of these drugs and the importing of these medicines.”
The administration has repeatedly attacked drug makers for the cost of their drugs and for making them less effective than other forms of prescription drugs.
It has also threatened to shut down their facilities, suspend their licenses, or sue them for allegedly making unsafe drugs.
But Trump’s announcement came after the FDA said it would approve the first of two drugs for a form of dementia known as Alzheimer’s disease, a move that could set the stage for a wave of lawsuits and potentially even the shutdown of many pharmaceutical companies.
The administration’s decision was a rare acknowledgment that drug makers could benefit from a government-led crackdown on the manufacturing and distribution of drugs.
The FDA, in a statement released by its office, said that its decision to approve the second drug in a drug class known as Vioxx is based on the “valid safety and efficacy data” it has reviewed, including evidence that the drug is effective in the treatment of severe depression and Alzheimer’s, and that it is safe and effective in younger patients.
The FDA said that the agency’s decision on Vioxy was based on “the validation of safety and effectiveness data that the manufacturer has provided, including data showing that the VioXX is effective and well tolerated in elderly patients with mild to moderate dementia.”
Vioxx, which was approved by the FDA in 2011, is a medication approved by two separate panels of experts from the National Institute of Mental Health and the National Institutes of Health, the U.S. government agency responsible for funding research into mental health.
It is the first drug approved for the treatment and prevention of dementia.
It is designed to be taken orally, which is much easier for people to take than it is to administer orally.
It can be taken by mouth, intravenously or by injection.
The drug is currently used in a small number of older adults, including in some of the nation’s biggest cities such as Los Angeles and New York.
Trump has repeatedly criticized drug makers and said he will keep working to make sure that drug prices are kept low.
The president recently said he had the authority to negotiate drug prices.
The move by the WhiteHouse came just days after the U,S.
Senate voted to reject a measure that would have forced drug makers, as well as the Medicare program that pays for most prescriptions, to lower drug prices for seniors.
Sen. Ron Wyden, a Democrat from Oregon, and other Democrats voted against the measure.
The measure was introduced by Sens.
Jon Tester of Montana, a Montana Democrat, and Jon Tiberi, a Georgia Democrat.
The House of Representatives also rejected a similar measure.
Trump also announced he would not use his power to block any of the 10 drug makers who are members of the Pharmaceutical Research and Manufacturers of America, a trade group that represents some of America’s largest pharmaceutical companies, including Merck, Pfizer, and Eli Lilly.
The White House did not immediately respond to a request for comment from Newsweek on the potential impact of the president’s comments on drug makers’ ability to sell drugs.